Stoneridge, Inc. (NYSE: SRI) designs and manufactures engineered electrical and electronic systems, components, and modules for commercial-vehicle, automotive, off-highway, and agricultural markets. Because it is a small-cap supplier followed by very few firms, it does not have a meaningful multi-analyst consensus. The $14.50 objective therefore comes from the fallback method: the most recent clearly attributable price objective in public discussion, which is Barrington Research analyst Gary Prestopino's target.
Prestopino has maintained an Outperform (Buy) rating on the stock. His target stood at $16 through late 2025 before being trimmed to $14.50 in November 2025, with the firm at one point framing the range as $13 to $16. Older consensus aggregations also reflected a second, lower target near $12, but that figure cannot be reliably attributed to a named analyst and date, so it is treated as context only. In short, the $14.50 figure is a single analyst's turnaround view, not an official published consensus.
Stoneridge shares closed near $5.41 on November 9, 2026, and trade within a 52-week range of roughly $4.60 to $9.71. Reaching $14.50 would require a gain of about 168% from the latest price, which qualifies as a very large move and would also take the stock well above its prior 52-week high.
The path would likely depend on a sustained earnings recovery. The company has been loss-making, with trailing EPS (earnings per share) around negative $4.29 and trailing-twelve-month net income deeply negative. Revenue, however, has been growing, and the stock trades at a price-to-sales ratio near 0.2, reflecting how much value the market has stripped from this cyclical, debt-heavy supplier. Any meaningful move toward $14.50 would require not only revenue growth but a genuine return to profitability.
The clearest bullish argument rests on Stoneridge's product transition. The MirrorEye camera-based mirror-replacement system has posted strong sales growth, and management has highlighted new program awards in Control Devices, including a significant OEM (original equipment manufacturer) program with substantial estimated lifetime revenue. Barrington's thesis points to improving operating margins, reduced quality-related costs, and a healthy backlog, even amid macro pressure. A cyclical rebound in commercial-vehicle production, successful MirrorEye adoption in Europe and North America, and debt reduction would all strengthen the case that the stock can re-rate meaningfully higher.
The obstacles are substantial. The company is not profitable on a trailing basis, carries roughly $149 million in debt against a modest equity base (a debt-to-equity ratio above 100%), and has twice amended credit terms to secure covenant relief. A weaker commercial-vehicle cycle, slower OEM adoption of new electronics, continued margin pressure, or further dilution to shore up the balance sheet could all keep the stock depressed. The thin analyst coverage also means there is little independent confirmation of the $14.50 objective, and the wide, aging $12-to-$16 range shows how uncertain the outlook is.
The stock's 52-week low near $4.60 and its 52-week high near $9.71 define the primary long-term range. Stoneridge slid sharply in early November 2026, trading down to roughly $4.78 before rebounding to $5.41, leaving the $5.00 round-number level and the $4.60 low as nearby support areas. On the upside, the $9.71 prior high is the first major resistance zone; a move toward $14.50 would require breaking decisively above that level, which would represent new multi-year territory.
Analyst price targets are typically anchored to a roughly 12-month research horizon, though the exact horizon of Barrington's $14.50 target is not specified. Investors should watch quarterly earnings and guidance, updates on MirrorEye sales and new program awards, any further credit-agreement amendments, and changes in commercial-vehicle production forecasts. Given the thin coverage, any analyst rating or target change carries outsized weight, and debt and cash-flow metrics deserve close attention.
For traders seeking a more systematic view, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual scanning. Consider exploring the signals page to see how AI evaluates Stoneridge alongside the broader market.
Whether Stoneridge can reach $14.50 hinges on a turnaround that has not yet materialized in the income statement. The objective is a single analyst's published target rather than a consensus, and it implies a very large gain of about 168% from the latest price near $5.41. The bullish case rests on MirrorEye momentum, new program wins, and margin improvement, while the bearish case rests on persistent losses, heavy leverage, and a cyclical, thinly covered business. Investors should treat $14.50 as a reference point, not a forecast, and focus next on earnings, guidance, and balance-sheet developments.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, SRI has been loosely correlated with MLR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRI jumps, then MLR could also see price increases.
| Ticker / NAME | Correlation To SRI | 1D Price Change % |
|---|---|---|
| SRI | 100% | +8.42% |
| Producer Manufacturing category (348 stocks) | 9% Poorly correlated | -1.29% |